GPC1 and neoplasm: For these reasons, functional neutralization of GPC1 by specific mAbs could potentially provide benefits by interfering with tumor growth, metastasis, and angiogenesis, and remodeling the tumor microenvironment to be more responsive to treatment and reduce immunosuppression.